AI blood test detects silent liver disease years before symptoms

An AI-driven blood test can detect silent liver disease years before symptoms appear. The novel liquid biopsy analyzes DNA fragmentation patterns, identifying early fibrosis and cirrhosis. This approach offers a significant advantage over current methods, potentially enabling earlier treatment and prevention of complications. This fragmentome technology, previously explored for cancer, shows promise for diagnosing other chronic conditions, with researchers planning further validation and expansion to other diseases.